Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.36B | 3.17B | 2.83B | 2.96B | 2.19B |
Gross Profit | 1.80B | 1.70B | 1.38B | 1.55B | 1.09B |
EBITDA | 719.12M | 696.64M | 464.09M | 627.01M | 295.21M |
Net Income | 408.00M | 404.10M | 220.46M | 360.82M | 107.76M |
Balance Sheet | |||||
Total Assets | 4.07B | 3.95B | 3.54B | 3.66B | 3.67B |
Cash, Cash Equivalents and Short-Term Investments | 816.83M | 697.69M | 447.72M | 638.00M | 702.65M |
Total Debt | 924.22M | 852.20M | 788.19M | 833.09M | 1.03B |
Total Liabilities | 1.35B | 1.31B | 1.21B | 1.30B | 1.41B |
Stockholders Equity | 2.72B | 2.63B | 2.32B | 2.35B | 2.25B |
Cash Flow | |||||
Free Cash Flow | 367.69M | 416.04M | 53.36M | 369.27M | 303.87M |
Operating Cash Flow | 521.19M | 575.76M | 238.72M | 510.72M | 376.32M |
Investing Cash Flow | -145.47M | -154.96M | -227.55M | -140.83M | -47.32M |
Financing Cash Flow | -227.70M | -173.64M | -184.09M | -439.50M | -32.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | €4.96B | 12.30 | 15.04% | 3.18% | 6.05% | 1.32% | |
46 Neutral | C$209.14M | -0.30 | -24.12% | 3.18% | 19.38% | -2.35% | |
― | €1.13B | 14.33 | 18.36% | ― | ― | ― | |
― | €227.87M | 11.20 | 3.72% | ― | ― | ― | |
75 Outperform | HK$20.13B | 34.83 | 24.57% | 0.68% | 13.58% | 24.59% | |
73 Outperform | HK$6.03B | 27.09 | 11.24% | 0.88% | 11.23% | 20.39% | |
64 Neutral | HK$11.93B | 240.89 | 1.33% | 0.66% | ― | ― |
Modern Dental Group Limited has announced a board meeting scheduled for August 28, 2025, to review and approve the unaudited interim results for the first half of 2025. The meeting will also consider the declaration or payment of dividends, which could impact the company’s financial strategy and shareholder returns.
Modern Dental Group Limited announced a positive profit alert for the first half of 2025, with expected revenue growth between 4.3% and 8.7%, and a net profit increase between 30.1% and 37.6% compared to the same period in 2024. The growth is attributed to organic expansion, improved operational efficiency through digital solutions, favorable currency movements, and the strategic acquisition of Hexa Ceram, enhancing the company’s market position and financial performance.
Modern Dental Group Limited reported a 5.3% increase in revenue for the first quarter of 2025, driven by strategic acquisitions and digital transformation efforts. Despite challenges in certain markets, the company has successfully leveraged global digitalization trends to enhance its competitiveness and market share, particularly through the acquisition of Hexa Ceram and a focus on mid- to high-value customers.
Modern Dental Group Limited held its annual general meeting on May 29, 2025, where all proposed resolutions were approved by shareholders. Key resolutions included the approval of the audited financial statements for 2024, the declaration of a final dividend, the re-election of directors, and the re-appointment of Ernst & Young as auditors. The meeting also granted the board general mandates to buy back shares and issue additional shares, reflecting shareholder confidence in the company’s strategic direction.
Modern Dental Group Limited has announced the appointment of Ms. Chan Yik Yu as a member of its nomination committee, effective from May 29, 2025. This strategic appointment is expected to enhance the company’s governance structure, potentially impacting its operational efficiency and stakeholder confidence.
Modern Dental Group Limited has announced the composition of its board of directors and the roles and functions of each member. This announcement highlights the company’s commitment to strong corporate governance and strategic leadership, which may impact its operational efficiency and market positioning positively.
Modern Dental Group Limited has updated the terms of reference for its Nomination Committee, initially adopted in 2015 and previously updated in 2018. The committee is tasked with ensuring a fair and transparent process for board appointments, identifying suitable candidates, and making recommendations to the board and shareholders. This update underscores the company’s commitment to robust governance practices, potentially enhancing its industry positioning and stakeholder trust.